Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Eculizumab for Refractory Thrombosis in Antiphospholipid Syndrome

Habiba Hussain, MD, Michael D Tarantino, MD, Keith R McCrae, MD, Shruti Chaturvedi, MBBS,MS, Jonathan C. Roberts, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-140535

Published: 2020

Journal Articles

Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Janna M. Journeycake, MD, Michael Recht, MD PhD, Christine Guelcher, Hemostasis RN-BC, MS, PPCNP-BC, Ellis J. Neufeld, Margaret V. Ragni, MDMPH, Robert F. Sidonio, Jr., MDMSc, Cliff Takemoto, Michael D Tarantino, MD, Dunlei Cheng, PhD, Susan U. Lattimore, Jorge Caicedo, Michael Denne, PharmD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138898

Published: 2020

Journal Articles

Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag

Michael D Tarantino, MD, Michael Vredenburg, PhD, Wei Tian, PhD, Brian Jamieson, MDBA, Kashyap B Patel, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-142788

Published: 2020

Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Courtney D Thornburg, MD, Kenneth D Friedman, MD, Michael F Guerrera, MD, Chunla He, Lynn M Malec, MD, Mindy L Simpson, MD, Michael D Tarantino, MD, H. Marijke Van Den Berg, Crystal Watson, BS, Shannon L Carpenter, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138748

Published: 2020

Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN

Blood (2019) 134 (Supplement_1): 1114.

https://doi.org/10.1182/blood-2019-128612

Published: 2019

Journal Articles

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, MD MRCP, FRPATH, James B. Bussel, MD, Michael D. Tarantino, MD, Nichola Cooper, Donald Beam, Jenny M. Despotovic, DO, Alexey A. Maschan, MD, Kejia Wang, PhD, Melissa Jeanne Eisen, MD, Charles Bowers, MD

Blood (2019) 134 (Supplement_1): 1095.

https://doi.org/10.1182/blood-2019-131241

Published: 2019

Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1069.

https://doi.org/10.1182/blood-2019-126473

Published: 2019

Journal Articles

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Michael D. Tarantino, MD, Jenny M. Despotovic, DO, MS, John Roy, John Grainger, MD MRCP, FRPATH, Nichola Cooper, MRCP, Donald Beam, Ashok Raj, Alexey A. Maschan, MD, June Kim, PhD, Melissa Jeanne Eisen, MD

Blood (2018) 132 (Supplement 1): 2428.

https://doi.org/10.1182/blood-2018-99-109763

Published: 2018

Journal Articles

Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis

Derek Weycker, PhD, Aaron Grossman, MD MPH, Ahuva Hanau, BS, Hongsheng Wu, PhD, Mark Hatfield, PhD, Anjali Sharma, MD, Mark E. Bensink, PhD MSc, MD, David Chandler, PhD, Michael D. Tarantino, MD

Blood (2018) 132 (Supplement 1): 2239.

https://doi.org/10.1182/blood-2018-99-113429

Published: 2018

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Michael D Tarantino, MD, James B. Bussel, MD, Victor S. Blanchette, MD FRCP, Jenny M. Despotovic, DO, MS, Carolyn Bennett, Ashok Raj, MD, Bronwyn Williams, Donald Beam, Jaime Morales, Melissa J. Rose, DO, Kun Nie, Melissa Eisen, MD

Blood (2015) 126 (23): 3467.

https://doi.org/10.1182/blood.V126.23.3467.3467

Published: 2015

Journal Articles

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)

Michael D Tarantino, MD, James B. Bussel, Victor S. Blanchette, Jenny Despotovic, Carolyn Bennett, Ashok Raj, MD, Bronwyn Williams, Donald Beam, Jaime Morales, Melissa J. Rose, Nancy Carpenter, Kun Nie, Melissa Eisen

Blood (2015) 126 (23): 7.

https://doi.org/10.1182/blood.V126.23.7.7

Published: 2015

Journal Articles

A Pilot Study to Assess Quality of Life in Older Children and Adolescents with Primary Immune Thrombocytopenia

Bianca Maya, MD, Caroline Kruse, Susan D. Mathias, MPH, Michael D. Tarantino, MD

Blood (2014) 124 (21): 4843.

https://doi.org/10.1182/blood.V124.21.4843.4843

Published: 2014

Journal Articles

Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Michael D. Tarantino, MD, James B. Bussel, MD, Amy Geddis, MD, Michael F. Guerrera, MD, Alan K. Ikeda, MD, Kun Nie, PhD, Melissa Eisen, MD

Blood (2013) 122 (21): 3530.

https://doi.org/10.1182/blood.V122.21.3530.3530

Published: 2013

Journal Articles

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),

Ann Janssens, MD, Michael D. Tarantino, MD, Robert Bird, MD, Maria Gabriella Mazzucconi, MD, Ralph Vincent V. Boccia, MD, Maria Fernanda Lopez-Fernandez, MD, Tomas Kozak, MD, Michael Steurer, MD, Peter A.W. Te Boekhorst, MD, PhD, Kerry Dillingham, MSc, Richard Lizambri, MD

Blood (2011) 118 (21): 3279.

https://doi.org/10.1182/blood.V118.21.3279.3279

Published: 2011

Journal Articles

Hemostatic Challenges In Patients Treated with Eltrombopag

Michael D. Tarantino, MD, Patrick F. Fogarty, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 2511.

https://doi.org/10.1182/blood.V116.21.2511.2511

Published: 2010

Journal Articles

Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study

Harold J. Olney, MD, CM, FRCP (C), Patrick F. Fogarty, MD, Michael D. Tarantino, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 2512.

https://doi.org/10.1182/blood.V116.21.2512.2512

Published: 2010

Journal Articles

U.S. Inhibitor Pilot Project: Participant Characteristics and Infusion Log Adherence.

Melissa S. Creary, MPH, John M. Soucie, PhD, Connie H. Miller, PhD, W.C. Hooper, PhD, Thomas C. Abshire, MD, Doreen B. Brettler, MD, Paula L. Pockenstedt, MD, Jorge DiPaola, MD, Gita Massey, MD, Anne T. Neff, MD, Amy D. Shapiro, MD, Michael D. Tarantino, MD, Brian M. Wicklund, MD, Donna DiMichele, MD, Hemophilia Treatment Centers

Blood (2007) 110 (11): 1162.

https://doi.org/10.1182/blood.V110.11.1162.1162

Published: 2007

Journal Articles

Cost-Minimization Analysis of Anti-D Immune Globulin Versus Intravenous Immune Globulin for the Initial Treatment of Immune Thrombocytopenic Purpura.

David A. Wetzel, PharmD, Michael D. Tarantino, MD

Blood (2006) 108 (11): 3305.

https://doi.org/10.1182/blood.V108.11.3305.3305

Published: 2006

Journal Articles

The Effect of Tumor Necrosis Factor (TNFα) Inhibition on Platelet Counts in Adults and Children with Persistent ITP.

Michael D. Tarantino, MD, Dana M. Stephens, RN, Karen L. Imfeld, Guy Young, MD, Shirley A. Williams, PhD, Yvonne L. Lucas, Diane J. Nugent, MD

Blood (2006) 108 (11): 1075.

https://doi.org/10.1182/blood.V108.11.1075.1075

Published: 2006

Journal Articles

Hematuria and Hemoglobinuria in Pediatric Patients Diagnosed with Newly Diagnosed Immune Thrombocytopenic Purpura.

Michael D. Tarantino, MD, Lisa C. Weber

Blood (2006) 108 (11): 1088.

https://doi.org/10.1182/blood.V108.11.1088.1088

Published: 2006

NARROW

Eculizumab for Refractory Thrombosis in Antiphospholipid Syndrome

Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)

A Pilot Study to Assess Quality of Life in Older Children and Adolescents with Primary Immune Thrombocytopenia

Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),

Hemostatic Challenges In Patients Treated with Eltrombopag

Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study

U.S. Inhibitor Pilot Project: Participant Characteristics and Infusion Log Adherence.

Cost-Minimization Analysis of Anti-D Immune Globulin Versus Intravenous Immune Globulin for the Initial Treatment of Immune Thrombocytopenic Purpura.

The Effect of Tumor Necrosis Factor (TNFα) Inhibition on Platelet Counts in Adults and Children with Persistent ITP.

Hematuria and Hemoglobinuria in Pediatric Patients Diagnosed with Newly Diagnosed Immune Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only